We use cookies on our website to make it clear, useful and reliable.In order to achieve this and to provide certain personalised features we store a small amount of data about you. To learn more visit Cookies: How we use the information on our website. By navigating from the front page to other sections of our website, you are consenting to information being stored.
Our latest news and events
Research is showing that persistent pain is a complex experience that has unequal impacts. In this blog Dr Whitney Scott, Lecturer in Clinical Health Psychology at King’s College London and Clinical Psychologist at the INPUT Pain Unit, part of Guy’s and St Thomas’ NHS Foundation Trust, draws on her work to explore how we can move toward greater equity in pain management.
By NIHR Maudsley BRC at 11 Jul 2022Professor Peter Goadsby, Theme lead for Pain at the National Institute for Health and Care Research (NIHR) Maudsley Biomedical Research Centre, has been elected to the Fellowship of the Royal Society, a Fellowship of many of the world’s most eminent scientists and the oldest academy in continuous existence.
By NIHR Maudsley BRC at 10 May 2022Multiple studies show that Vulvodynia is a widespread condition that involves persistent pain in the vulva, which refers to external female genitalia. However, Vulvodynia remains largely underdiagnosed and under-researched and has poor treatment options. In this blog, Claudia Chisari, a final year NIHR Maudsley BRC PhD Candidate, discusses Vulvodynia, the lessons learnt from her research, and recommendations to improve support for people living with it.
By NIHR Maudsley BRC at 23 Nov 2021Peter Goadsby, Professor of Neurology at King's College London’s Institute of Psychiatry, Psychology & Neuroscience (IoPPN), and Director at the National Institute for Health Research-Wellcome Trust Clinical Research Facility (NIHR CRF), King's College Hospital has been awarded the world’s top Brain Prize from the Lundbeck Foundation for his pioneering migraine research.
By NIHR Maudsley BRC at 4 Mar 2021Fremanezumab, a new drug preventing chronic migraine, has been recommended in final draft guidance from National Institute for health and Care Excellence (NICE) today (12 March 2020) following clinical trials based on research led by King’s College London.
By NIHR Maudsley BRC at 12 Mar 2020
The NIHR Maudsley Biomedical Research Centre (BRC) is part of the NIHR and hosted by South London and Maudsley NHS Foundation Trust in partnership with King's College London. We are part of King’s Health Partners Academic Health Sciences Centre.
© NIHR Maudsley Biomedical Research Centre 2024 | Website design by CSMB Design | All rights reserved.
